March 8, 2007
Alitretinoin results positive in Hand dermatitis
Analysis of:
Basilea Reports Positive Phase III Results for Alitretinoin | www.pipelinereview.com
This analysis is solely the work of the author. It has not been edited or endorsed by GLG.
Implications: This large phase 3 trial for Alitretinoin results are significant in the this would be the first oral agent specifically for resistant hand dermatitis. the results are positive with good significance. The major problem will be getting the FDA to accept the drug without the onerous pregnancy prevention programs associated with other retinoids like Accutane, etc. This is why the trial was done in Europe, and not in the US!!
Analysis: It will compare well, in that it has good results, and most patients prefer to take an oral agent, rather than applying a topical agent. The major hurdle will be to get the FDA to approve the drug without the pregnancy prevention program associated with other retinoids.
Analysis: It will compare well, in that it has good results, and most patients prefer to take an oral agent, rather than applying a topical agent. The major hurdle will be to get the FDA to approve the drug without the pregnancy prevention program associated with other retinoids.
Report a Concern
More GLG News in
Healthcare
Most Popular:
Source Article | Expert Analyses
Merck KGaA: Overall Survival in First-Line NSCLC Reaches 15 Months
www.pipelinereview.com
Hospitals See Drop in Paying Patients
www.nytimes.com
Painkiller Risk Found for Heart Patients
www.nytimes.com
Gardasil, Merck's Cervical Cancer Vaccine, Demonstrated Efficacy in Preventing HPV-Related Disease in Males in Phase III Study
www.fiercebiotech.com
FDA Asks if Pain Pill Is Tamper-Proof
online.wsj.com
Will contact lens solutions cost more to ship and store?
November 13, 2008
Economy's impact on healthcare facilities
November 13, 2008
Tamper Proof Narcotic Pain pill? YES
November 13, 2008
CVS Escalates the Generic Price War
November 13, 2008
A closer look
November 11, 2008

